Objective To examine whether a more conservative approach to treating patent ductus arteriosus (PDA) is associated with an increase or decrease in morbidity compared with an approach involving early PDA ligation.
Conclusions
See editorial, p 355 P ersistent patent ductus arteriosus (PDA) can produce alterations in renal, mesenteric, and cerebral perfusion as well as pulmonary edema in preterm infants. Early indomethacin treatment has been studied in numerous randomized controlled trials (RCTs) and was found to decrease symptomatic PDA and to also decrease the incidence of early severe pulmonary and intracranial hemorrhage (ICH). [1] [2] [3] [4] [5] [6] [7] Little information is available to guide neonatologists on actions to take when the PDA fails to close after indomethacin treatment, however.
Two small RCTs performed almost 30 years ago were designed to examine the effects of a persistent symptomatic PDA on neonatal pulmonary morbidity. 8, 9 Both studies found that surgical closure of PDA decreased the need for prolonged ventilatory support; significant pulmonary morbidity occurred in patients without PDA ligation when signs of congestive failure developed. 8, 9 Whether these findings are still applicable in the setting of modern neonatal treatment (eg, antenatal glucocorticoids, surfactant replacement therapy) remains a matter of controversy among neonatologists. 10 The relationship between persistent PDA and necrotizing enterocolitis (NEC) is even more controversial. Although population-based studies have reported an association between a PDA and NEC, [11] [12] [13] no RCT reported to date has examined the advisability of continuing or stopping enteral feeding in the presence of a PDA.
Surgical ligation produces definitive PDA closure; however, it is associated with its own set of morbidities, including thoracotomy, pneumothorax, chylothorax, postoperative hypotension, vocal cord paralysis, infection, and scoliosis. [14] [15] [16] 17 In addition, several studies have suggested that early surgical ligation may have detrimental effects on lung function and growth and might even contribute to the development of bronchopulmonary dysplasia (BPD). [18] [19] [20] [21] This finding raises the possibility that PDA ligation might create problems that could counteract any of the benefits derived from PDA closure. 18, 19 Because preterm infants have a high rate of spontaneous PDA closure during the first 2 years after birth, early ligation may expose these infants to a surgery that they might not need. Currently there are significant differences of opinion in the 22 We examined whether a more conservative approach to PDA treatment in infants delivered at #27 6/7 weeks gestation who did not experience PDA closure after indomethacin treatment was associated with increased or decreased morbidity compared with an approach involving early surgical ligation.
Methods
This project design was approved by the University of California San Francisco's Institutional Review Board. Between January 1999 and July 2009, all infants #27 6/7 weeks gestation admitted to the William H. Tooley Nursery at University of California San Francisco were treated with a course of prophylactic indomethacin starting within 15 hours of birth provided that there were no contraindications. A full description of this approach has been published elsewhere. 19 An echocardiogram was performed 24-36 hours after the last dose to determine the response of the PDA to prophylactic indomethacin.
After prophylactic treatment, infants were examined daily for the appearance of clinical symptoms indicative of PDA (eg, systolic murmur, widened pulse pressure, hyperdynamic precordium). If any of these occurred, an echocardiogram was performed within 24 hours. If a left-to-right flow through the PDA was noted, the infant was considered to have a symptomatic PDA. An infant with a symptomatic PDA could be treated with a second course of indomethacin. The decision of whether or not to administer a second course of indomethacin was based mainly on the response of the infant's PDA to the initial prophylactic indomethacin course, 23 not on the infant's medical condition. Infants with a PDA that initially closed after prophylactic indomethacin were more likely to be treated with a second course of indomethacin if symptoms developed, because the likelihood of permanent closure was considered much greater in these infants than in infants in whom the PDA did not completely close after initial treatment. 23 During the study period, 2 different approaches were used to treat a symptomatic PDA that failed to close after 1 or 2 courses of indomethacin. During period 1 (January 1999 through December 2004), an early surgical approach was used to treat a PDA that failed to close after indomethacin. Enteral feedings were stopped, and all PDAs were surgically ligated as soon as possible. The decision to ligate was not dependent on the need for respiratory support or the degree of left-to-right shunt. Even infants who required only nasal cannula oxygen underwent ligation if the ductus was patent on the echocardiogram. The rationale behind this early surgical approach was based on a review of previous RCTs that examined the morbidities of prolonged exposure to a symptomatic PDA. 8, 9 In January 2005, we changed our treatment approach. During period 2 (January 2005 through July 2009), a more conservative approach was used to treat a symptomatic PDA that failed to close after indomethacin treatment. Enteral feedings were continued despite the presence of a persistent PDA, and a PDA was ligated only if symptoms of cardiopulmonary compromise developed. Cardiopulmonary compromise related to the PDA was defined as the presence of one or more of the following symptoms: increasing ventilatory requirement over several days, persistent hypotension requiring inotropic support, persistent oliguria/renal failure, or feeding intolerance/failure to gain weight. These symptoms were attributed to the PDA only when no other explanation could be found to explain the infant's deteriorating condition. There were no changes in our protocols for prophylactic indomethacin, feeding advances, or ventilator management between the 2 periods.
Risk Factors and Outcome Variables
A single neonatologist (R.C.) prospectively evaluated and recorded all of the perinatal/neonatal risk factors and outcome measures during the period of hospitalization ( Table I) . Gestational age was determined by the date of the last menstrual period and early ultrasound examinations (before 24 weeks gestation). If there were discrepancies, the early ultrasound dating was used. NEC was defined as Bell's classification II or greater; this included cases of NEC treated medically or surgically, as well as ''spontaneous perforations'' occurring before 7 days. 24 BPD was defined as a supplemental oxygen requirement at 36 weeks gestational age to maintain oxygen saturation >90%. Retinopathy of prematurity (ROP) was defined as stage 2 (with plus disease) or stage 3 or greater. 25 Intracranial hemorrhage (ICH) was classified using a 4-level grading system. 26 Periventricular leukomalacia (PVL) was defined as echodensities on ultrasonography that progressed to cystic degeneration. All infants were examined by serial bedside cranial ultrasonography, initiated within the first week of life. These were repeated weekly or biweekly for the first 4 weeks. After 1 month, imaging was repeated before discharge or more frequently if abnormal findings were noted.
Echocardiographic studies included 2-dimensional imaging, M-mode, color flow mapping, and Doppler interrogation. 27 A single cardiologist (A.M.-G.), blinded to clinical data interpreted all of the echocardiograms. The ductus arteriosus was classified as either closed or open; in open cases, the left-to-right shunt was classified as small, moderate, or large. The magnitude of the left-to-right shunt was based on the presence of a combination of echocardiographic measures considered to reflect the degree of PDA shunt [28] [29] [30] [31] : ductus diameter $1.5 mm, left atrium-to-aortic root (LA/Ao) ratio $1.6, and a holodiastolic reversal of flow in the descending aorta (at the level of the diaphragm) ( 
Statistical Models
The c 2 test was used to compare qualitative factors. The Student t test or Mann-Whitney test was used to compare means and median values. We used an adjusted logistic regression model to determine whether the change in PDA treatment approach (among infants that failed to close their PDA after 1 or 2 courses of indomethacin) had an effect on neonatal morbidity. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a multivariate model that included treatment approach, gestation, period of admission, plus each of the following perinatal/neonatal risk factors: antenatal betamethasone, preeclampsia, chorioamnionitis, male sex, and Respiratory Severity Score (RSS) (mean airway pressure Â fraction of inspired oxygen at 24 hours after birth). A P value <.05 was considered significant.
Results
Infants who died #4 days before the first echocardiographic evaluation were excluded from the analysis (Figure) . There were no differences between period 1 and period 2 in the percentages of infants that were excluded from the study (11% due to early death) or did not experience permanent PDA closure after prophylactic indomethacin treatment, were retreated with indomethacin, failed indomethacin retreatment, or were considered to have failed indomethacin treatment (24%) (Figure) . There also were no differences between the 2 periods in the prevalence of perinatal or neonatal risk factors (except chorioamnionitis) or of neonatal morbidities ( Table I) . The same findings were observed when we examined the subpopulation of infants that had permanent ductus closure after indomethacin treatment ( Table I) .
Infants Who Failed Indomethain Treatment
Among the infants who failed indomethacin treatment, there were no differences in the prevalence of perinatal and neonatal risk factors (except male sex) between those treated with early surgery (period 1) and those treated with a more conservative approach (period 2) ( Table III) . The infants who failed indomethacin treatment did so at an earlier age during period 2 compared with period 1 (Table III) , due to differences in the initial pattern of response to indomethacin prophylaxis. During period 1, 46% of the infants who ultimately failed indomethacin treatment did not achieve PDA closure with the initial indomethacin prophylaxis; the other 54% initially had PDA closure with indomethacin prophylaxis but experienced subsequent reopening. In contrast, during period 2, 86% of the infants who ultimately failed indomethacin treatment failed to achieve PDA closure with initial indomethacin prophylaxis, and 14% failed after the reopening of a PDA that had closed after indomethacin prophylaxis.
During period 1, 100% of the 52 infants who failed indomethain treatment underwent surgical ligation ( Table III) . The interval between the echocardiogram that documented the presence of a persistent PDA and ligation (2.3 AE 2.3 days) varied according to the availability of a surgeon and/ or the need to clear ongoing bacteremia (Table III) .
During period 2, infants who failed indomethacin treatment underwent ligation only if they developed specific symptoms. Of the 43 infants treated during period 2, 31 (72%) met the criteria for ligation and underwent ligation before discharge from the hospital ( Table III) . The primary reasons for ligation were increasing ventilatory requirement (87%) and/or persistent hypotension requiring inotropic support (39%) that could not be explained by other causes. Some 10% of the infants who underwent ligation also had persistent oliguria/renal failure that could not be explained by other causes. None of the infants had feeding intolerance or failure to gain weight as a reason for ligation. Infants born at 24-25 weeks gestation were more likely to develop criteria for ligation (81%) compared with those born at 26-27 weeks gestation (56%). During period 2, 28% (12/43) of the conservatively treated infants never met the criteria for ligation during the neonatal period. Eight of these 12 achieved PDA closure spontaneously by 6 months corrected age (4 before and 4 after hospital discharge), and the other either underwent PDA closure via transcatheter coil embolization or had an open PDA being followed at 12-18 months corrected age. Although the size of the PDA shunt at the time of failure of indomethacin treatment was similar in the 2 groups, the infants treated during period 2 were ultimately exposed to significantly larger PDA shunts for significantly longer periods (Table III) .
We used multivariate models that included gestation, period of admission, and one or more perinatal/neonatal risk factors to determine whether the change from an early surgical approach to a more conservative approach was associated with an increase or a decrease in neonatal morbidity ( Table IV) . The rates of BPD, sepsis, ROP, neurologic injury, death, and death or BPD were not significantly different between the 2 treatment approaches; however, with our sample size, we only had sufficient power to detect a difference of >20% between the 2 treatment approaches (Table IV) . In the multivariate model, the rate of NEC was significantly lower THE JOURNAL OF PEDIATRICS www.jpeds.com Vol. 157, No. 3 in infants treated during period 2 compared with those treated during period 1. The incidence of NEC occurring after assignment of infants to the different treatment approaches tended to be lower in the infants assigned to period 2 (P = .053) ( Table IV) .
Discussion
This study spanning 2 consecutive time periods found no significant differences in the rates of BPD, sepsis, ROP, neurologic injury, or mortality between infants treated with early PDA surgery and those treated more conservatively (with surgical ligation only if the PDA was hemodynamically significant after failure of indomethacin treatment). We found a decreased risk of NEC in the more conservatively treated infants. Although the more conservative approach still resulted in eventual surgical ligation in the majority of infants, a significant number of infants did not undergo surgery before hospital discharge, and several achieved spontaneous PDA closure despite initial failure of indomethacin therapy.
Our study was not an RCT, because we were unable to find any neonatal units in which the medical and nursing staffs felt that they could successfully randomize and implement the 2 different surgical approaches concurrently without introducing significant bias into their treatment decisions. Therefore, we evaluated the effects of a change in practice between 2 consecutive time periods. Even though our study cannot provide definitive evidence of the benefits of one treatment over the other, several features give us some confidence in the associations that we observed.
During the years bracketed by our study, there appeared to be no significant changes in our study population in the prevalence of perinatal and neonatal risk factors (except for clinical chorioamnionitis) or in the prevalence of neonatal morbidities (compare periods 1 and 2; Table I), nor were there changes in our protocols for prophylactic indomethacin, feeding advances, or ventilator management during these periods.
A treatment approach was uniformly applied to all infants during each study period; that is, no infants were treated with an aggressive treatment approach during period 2, and no infants were treated with a conservative approach during period 1.
Multivariate statistical models were used to adjust for potential differences between the 2 treatment approaches that might be due to differences in period of birth or in other perinatal or neonatal risk factors.
For our study, we chose a ''conservative'' treatment approach that included an option for surgical ligation if symptoms of cardiopulmonary compromise developed. Although some authors have argued that any benefits derived from PDA ligation are outweighed by the risks of ligation, 10 we did not feel that there was sufficient evidence to completely abandon the use of ligation. Numerous previous studies have demonstrated that infants with clinical and radiographic signs of pulmonary edema exhibit improved lung compliance after surgical ligation. [32] [33] [34] [35] In addition, the only RCTs to date that have examined PDA ligation versus no intervention to close a persistent PDA found significant pulmonary morbidity in the group that was not allowed to undergo PDA ligation when signs of congestive failure developed. 8, 9 To date, no RCT has addressed the pros or cons of continuing enteral feeding in the presence of a PDA. Hemodynamic studies have shown that a PDA decreases mesenteric blood flow during both fasting and fed states, [36] [37] [38] and population-based, retrospective, observational studies have found an association between the presence of a PDA and NEC. [11] [12] [13] Currently, 70% of neonatologists in the United States believe that enteral feedings should be stopped in the presence of a symptomatic PDA. 22, 39 In our study, infants treated with the conservative approach received enteral feedings despite the presence of a PDA. It is interesting to note that the rate of NEC was lower in the infants treated with the conservative approach compared with those treated with early surgery. This finding appears to support the feeding approach used by neonatologists outside of the United States, 70% of whom believe that enteral feedings should continue in the presence of a symptomatic PDA. 22 Despite our desire to avoid ligation in infants treated with the conservative approach, 72% of the infants ultimately met the criteria for ligation and underwent ligation during the neonatal period. The likelihood that infants would meet ligation criteria during the neonatal period was inversely related to their gestational age; infants born at 24-25 weeks gestation were much more likely to meet ligation criteria (81%) than those born at 26-27 weeks (56%). The ligation rate continued to drop among more mature infants; only 14% of infants born at 28-29 weeks gestation who were managed with the same conservative treatment approach (after failing to close their PDA with indomethacin) ultimately met the criteria for ligation criteria (data not shown).
Although most of the conservatively treated immature infants ultimately met the criteria for ligation, they had a significantly longer delay (13 AE 8 days) before ligation compared with infants who underwent ligation during the early surgery period (2.4 AE 2.3 days). The delay in ligation might have been beneficial, given that accumulating evidence suggests that several of the morbidities associated with ligation (ie, hypotension and need for inotropic support, 17, 40 vocal cord paralysis, 15 and BPD 18, 41 ) are significantly reduced when ligation is delayed.
In conclusion, we examined the effects of a conservative approach to treating PDAs that fail to close after indomethacin treatment. We found that a conservative approach that tolerates the presence of a PDA as long as signs of cardiopulmonary compromise do not develop is associated with a 28% decrease in the rate of ductus ligation and lower rates of NEC. These findings support the need for new RCTs to reexamine the benefits and risks of different approaches to treating PDA in the modern era. n The logistic regression neonatal morbidity models were constructed as described in Methods. The ORs in the table are for the morbidity models that included the total study population (n = 396, see Figure) and the following variables: treatment approach (examined as a trivariate vari NA, not applicable. *A ductal diameter of <1.5 mm was accepted if all other criteria for ''moderate'' were met. †Ductal diameter $1.5 mm plus all other, or >2.0 mm plus one other criterion for ''large'' resulted in a categorization of ''large.''
